Michalis Karamouzis
TitleCited byYear
Head and neck cancer
A Argiris, MV Karamouzis, D Raben, RL Ferris
The Lancet 371 (9625), 1695-1709, 2008
14872008
Machine learning applications in cancer prognosis and prediction
K Kourou, TP Exarchos, KP Exarchos, MV Karamouzis, DI Fotiadis
Computational and structural biotechnology journal 13, 8-17, 2015
6722015
Post-translational modifications and regulation of the RAS superfamily of GTPases as anticancer targets
PA Konstantinopoulos, MV Karamouzis, AG Papavassiliou
Nature reviews Drug discovery 6 (7), 541, 2007
4642007
A phase I trial of adoptive transfer of allogeneic natural killer cells in patients with advanced non-small cell lung cancer
EG Iliopoulou, P Kountourakis, MV Karamouzis, D Doufexis, A Ardavanis, ...
Cancer immunology, immunotherapy 59 (12), 1781-1789, 2010
2012010
Therapies directed against epidermal growth factor receptor in aerodigestive carcinomas
MV Karamouzis, JR Grandis, A Argiris
Jama 298 (1), 70-82, 2007
1942007
Assessing the carcinogenic potential of low-dose exposures to chemical mixtures in the environment: the challenge ahead
WH Goodson III, L Lowe, DO Carpenter, M Gilbertson, A Manaf Ali, ...
Carcinogenesis 36 (Suppl_1), S254-S296, 2015
1642015
Stereotactic body radiotherapy for recurrent squamous cell carcinoma of the head and neck: results of a phase I dose-escalation trial
DE Heron, RL Ferris, M Karamouzis, RS Andrade, EL Deeb, S Burton, ...
International Journal of Radiation Oncology* Biology* Physics 75 (5), 1493-1500, 2009
1462009
Targeting MET as a strategy to overcome crosstalk-related resistance to EGFR inhibitors
MV Karamouzis, PA Konstantinopoulos, AG Papavassiliou
The lancet oncology 10 (7), 709-717, 2009
1202009
Phase II trial of pemetrexed and bevacizumab in patients with recurrent or metastatic head and neck cancer
A Argiris, MV Karamouzis, WE Gooding, BF Branstetter, S Zhong, ...
Journal of Clinical Oncology 29 (9), 1140, 2011
1072011
Matrix metalloproteinase inhibitors as anticancer agents
PA Konstantinopoulos, MV Karamouzis, AG Papatsoris, AG Papavassiliou
The international journal of biochemistry & cell biology 40 (6-7), 1156-1168, 2008
952008
Asymptomatic adult cystic lymphangioma of the spleen: case report and review of the literature
EG Solomou, GV Patriarheas, FA Mpadra, MV Karamouzis, I Dimopoulos
Magnetic resonance imaging 21 (1), 81-84, 2003
782003
Novel insights into the implication of the IGF-1 network in prostate cancer
AG Papatsoris, MV Karamouzis, AG Papavassiliou
Trends in molecular medicine 11 (2), 52-55, 2005
762005
Transcription factors and neoplasia: vistas in novel drug design
MV Karamouzis, VG Gorgoulis, AG Papavassiliou
Clinical cancer research 8 (5), 949-961, 2002
742002
PPAR-gamma is expressed and NF-kB pathway is activated and correlates positively with COX-2 expression in stromal myofibroblasts surrounding colon adenocarcinomas
GP Vandoros, PA Konstantinopoulos, G Sotiropoulou-Bonikou, ...
Journal of cancer research and clinical oncology 132 (2), 76-84, 2006
722006
Intratumoral doxorubicin in patients with malignant brain gliomas
S Voulgaris, M Partheni, M Karamouzis, P Dimopoulos, N Papadakis, ...
American journal of clinical oncology 25 (1), 60-64, 2002
682002
Breast cancer: the upgraded role of HER-3 and HER-4
MV Karamouzis, FA Badra, AG Papavassiliou
The international journal of biochemistry & cell biology 39 (5), 851-856, 2007
642007
Non‐palpable breast carcinomas: Correlation of mammographically detected malignant‐appearing microcalcifications and molecular prognostic factors
MV Karamouzis, E Likaki‐Karatza, P Ravazoula, FA Badra, D Koukouras, ...
International journal of cancer 102 (1), 86-90, 2002
612002
Roles of CREB-binding protein (CBP)/p300 in respiratory epithelium tumorigenesis
MV Karamouzis, PA Konstantinopoulos, AG Papavassiliou
Cell research 17 (4), 324, 2007
592007
The FOXE1 locus is a major genetic determinant for familial nonmedullary thyroid carcinoma
E Bonora, C Rizzato, C Diquigiovanni, T Oudot‐Mellakh, D Campa, ...
International journal of cancer 134 (9), 2098-2107, 2014
58*2014
Phase II study of pegylated liposomal doxorubicin (Caelyx®) and docetaxel as first-line treatment in metastatic breast cancer
A Alexopoulos, MV Karamouzis, H Stavrinides, A Ardavanis, K Kandilis, ...
Annals of oncology 15 (6), 891-895, 2004
552004
The system can't perform the operation now. Try again later.
Articles 1–20